Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.27 is 23% below its 5-year average of 5.55, near the low end of its 5-year range (0.40–14.08).
As of the fiscal period ended Tuesday, June 30, 2026. 199.48% above its 12-month average of 1.43.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.27.
CURRENT RATIO
4.27
CURRENT RATIO AVG TTM
1.43
CURRENT RATIO AVG 3Y
2.81
CURRENT RATIO AVG 5Y
5.55
CURRENT RATIO AVG 10Y
5.16
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+199.48%
CURRENT VS 3Y AVG
+51.81%
CURRENT VS 5Y AVG
-23.12%
CURRENT VS 10Y AVG
-17.27%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+13.85%
vs the sector median at left
Market Cap
$24.64M
Current Ratio
5.69
TTM Avg
10.26
3Y Avg
14.84
5Y Avg
17.88
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rein Therapeutics Inc. (RNTX) | $23.00M | 4.27 | 1.43 | 2.81 | 5.55 |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.15M | 3.22 | 2.47 | 1.96 | 1.75 |
| LeonaBio, Inc. (LONA)vs › | $22.24M | 7.01 | 3.03 | 5.28 | 15.47 |
| Kyntra Bio, Inc. (KYNB)vs › | $23.88M | 2.69 | 2.43 | 2.04 | 2.49 |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.18M | 0.07 | 0.37 | 0.39 | 0.82 |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 1.13 | 1.19 | 1.11 | 1.05 |
| Modular Medical, Inc. (MODD)vs › | $22.09M | 3.25 | 7.36 | 6.38 | 5.95 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.64M | 5.69 | 10.26 | 14.84 | 17.88 |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.44M | 1.20 | 1.44 | 1.90 | 2.95 |
| InspireMD, Inc. (NSPR)vs › | $26.70M | 3.80 | 5.51 | 5.64 | 5.87 |
Current Ratio
4.27
Quick Ratio
4.27
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.27 |
| 2026-03-31 | 0.40 |
| 2025-12-31 | 0.70 |
| 2025-09-30 | 0.90 |
| 2025-06-30 | 0.86 |
| 2025-03-31 | 1.39 |
| 2024-12-31 | 2.38 |
| 2024-09-30 | 3.30 |
| 2024-06-30 | 4.69 |
| 2024-03-31 | 2.82 |
| 2023-12-31 | 4.17 |
| 2023-09-30 | 7.88 |
| 2023-06-30 | 11.66 |
| 2023-03-31 | 5.93 |
| 2022-12-31 | 6.46 |
| 2022-09-30 | 5.96 |
| 2022-06-30 | 6.51 |
| 2022-03-31 | 9.65 |
| 2021-12-31 | 10.69 |
| 2021-09-30 | 11.93 |
| 2021-06-30 | 14.08 |
| 2021-03-31 | 20.93 |
| 2020-12-31 | 4.12 |
| 2020-09-30 | 3.04 |
| 2020-06-30 | 3.99 |
| 2020-03-31 | 2.23 |
| 2019-12-31 | 3.35 |
| 2019-09-30 | 4.12 |
| 2019-06-30 | 6.04 |
| 2019-03-31 | 3.11 |
| 2018-12-31 | 4.05 |
| 2018-09-30 | 4.23 |
| 2018-06-30 | 5.85 |
| 2018-03-31 | 9.15 |
| 2017-12-31 | 10.60 |
| 2017-09-30 | 11.57 |
| 2017-06-30 | 2.19 |
| 2017-03-31 | 5.57 |
| 2016-12-31 | 5.18 |
